Notice of Closed Meeting, 9520 [2018-04479]
Download as PDF
<![CDATA[
9520
Federal Register / Vol. 83, No. 44 / Tuesday, March 6, 2018 / Notices
SYSTEM LOCATION:
Federal Housing Finance Agency, 400
Seventh Street SW, Washington, DC
20219, and any alternate work site
utilized by employees of the Federal
Housing Finance Agency (FHFA) or by
individuals assisting such employees.
SYSTEM MANAGER(S):
Office of General Counsel, Federal
Housing Finance Agency, 400 Seventh
Street SW, Washington, DC 20219.
PURPOSE(S) OF THE SYSTEM:
The purpose of the System is
expanded to include collecting
information from other organizations
and entities that voluntarily submit
reports to FHFA about counterparties
that have engaged in covered
misconduct as defined in the
Suspended Counterparty Regulation at
12 CFR 1227.2.
ROUTINE USES OF RECORDS MAINTAINED IN THE
SYSTEM, INCLUDING CATEGORIES OF USERS AND
THE PURPOSE OF SUCH USES:
(13) To an FHFA regulated entity.
(14) To state and federal housing or
financial regulators.
(15) To state or federal professional
licensing agencies.
HISTORY:
The FHFA Suspended Counterparty
System (FHFA–23) system of records
was last published in the Federal
Register on November 25, 2014 (79 FR
70181).
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
SIP18–001, Targeting Treatment Gaps:
Describing When, How Quickly, And
Why Persons with Epilepsy Are
Referred For Specialty Care.
Date: April 25, 2018.
Time: 11:00 a.m.–4:00 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Jaya
Raman, Ph.D., Scientific Review Officer,
CDC, 4770 Buford Highway, Mailstop
F80, Atlanta, Georgia 30341, Telephone:
(770) 488–6511, kva5@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2018–04479 Filed 3–5–18; 8:45 am]
BILLING CODE 4163–18–P
Dated: February 28, 2018.
Melvin L. Watt,
Director, Federal Housing Finance Agency.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2018–04527 Filed 3–5–18; 8:45 am]
Centers for Disease Control and
Prevention
BILLING CODE 8070–01–P
Advisory Council for the Elimination of
Tuberculosis Meeting (ACET)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
Centers for Disease Control and
Prevention
sradovich on DSK3GMQ082PROD with NOTICES
Notice of Closed Meeting
VerDate Sep<11>2014
21:39 Mar 05, 2018
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
of the Advisory Council for the
Elimination of Tuberculosis Meeting
(ACET). This meeting is open to the
public, limited only by 100 room seating
and 100 ports for audio phone lines.
Time will be available for public
comment. The public is welcome to
submit written comments in advance of
the meeting. Comments should be
submitted in writing by email to the
contact person listed below. The
deadline for receipt is Monday, April 9,
2018. Persons who desire to make an
oral statement, may request it at the
SUMMARY:
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Management Analysis and
Services Office, CDC, pursuant to Public
Law 92–463. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
Jkt 244001
PO 00000
Frm 00047
Fmt 4703
Sfmt 9990
time of the public comment period on
April 17, 2018 at 3:20 p.m. EDT. This
meeting is accessible by web
conference: 1–877–927–1433 and
participant passcode: 12016435 and
https://adobeconnect.cdc.gov/
r5p8l2tytpq/.
The meeting will be held on
April 17, 2018, 8:30 a.m. to 3:30 p.m.,
EDT.
DATES:
8 Corporate Blvd., Building
8, Conference Rooms 1A and 1B,
Atlanta, Georgia, 30329 and web
conference.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Margie Scott-Cseh, Committee
Management Specialist, CDC, 1600
Clifton Road NE, Mailstop: E–07,
Atlanta, Georgia, 30329, telephone (404)
639–8317; zkr7@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: This Council advises and
makes recommendations to the
Secretary of Health and Human
Services, the Assistant Secretary for
Health, and the Director, CDC, regarding
the elimination of tuberculosis.
Specifically, the Council makes
recommendations regarding policies,
strategies, objectives, and priorities;
addresses the development and
application of new technologies; and
reviews the extent to which progress has
been made toward eliminating
tuberculosis.
Matters to be Considered: The agenda
will include: (1) Update on Report of
Verified Case of Tuberculosis (RVCT)
revision; (2) Overview of Division of
Global Migration and Quarantine
(DGMQ) TB Technical Instructions; (3)
Update on healthcare workers screening
guidelines; and (4) Updates from ACET
workgroups. Agenda items are subject to
change as priorities dictate.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2018–04477 Filed 3–5–18; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\06MRN1.SGM
06MRN1
]]>Agencies
[Federal Register Volume 83, Number 44 (Tuesday, March 6, 2018)]
[Notices]
[Page 9520]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-04479]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Management
Analysis and Services Office, CDC, pursuant to Public Law 92-463. The
grant applications and the discussions could disclose confidential
trade secrets or commercial property such as patentable material, and
personal information concerning individuals associated with the grant
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)--SIP18-001, Targeting Treatment
Gaps: Describing When, How Quickly, And Why Persons with Epilepsy Are
Referred For Specialty Care.
Date: April 25, 2018.
Time: 11:00 a.m.-4:00 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Jaya Raman, Ph.D., Scientific
Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta,
Georgia 30341, Telephone: (770) 488-6511, [email protected].
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2018-04479 Filed 3-5-18; 8:45 am]
BILLING CODE 4163-18-P
